CAJ | 학술논문

为了评价医药类上市公司的综合实力和制定相应的经营战略，以15家上市公司为研究对象，以近5年数据为样本，运用因子分析法建立了企业综合实力-企业综合实力增长率战略模型，绘制出相应战略决策图。根据此图，可以实现医药类上市公司综合实力水平的评价，为企业决策者制定正确战略决策提供科学依据。
위료평개의약류상시공사적종합실력화제정상응적경영전략，이15가상시공사위연구대상，이근5년수거위양본，운용인자분석법건립료기업종합실력-기업종합실력증장솔전략모형，회제출상응전략결책도。근거차도，가이실현의약류상시공사종합실력수평적평개，위기업결책자제정정학전략결책제공과학의거。
In order to evaluate the comprehensive strength of the pharmaceutical listing companies, and to formulate corresponding strategies,the 15 listed companies were taken as the research objects and nearly five years of data were taken as the samples, and the strategy model of the enterprise comprehensive strength - growth rate of the enterprise comprehensive strength was established by using factor analysis. And the corresponding strategy policy chart was drawn out. According to the chart, thus valuation of the comprehensive strength of pharmaceutical listed companies was realized, which provides scientific basis for decision-maker to formulate the correct strategic decisions.